Synopsis
Synopsis
0
USDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4-isopropyl-2,3-dimethyl-1-phenyl-3-pyrazoline-5-one
2. 4-isopropylantipyrine
3. Commotional
4. Demex
5. Hewedolor Propy
6. Isoprochin P
7. Isopropylphenazone
8. Propylphenazone
1. Isopropyl Phenazone
2. 479-92-5
3. Isopropylantipyrine
4. Isopropylphenazone
5. 4-isopropylantipyrine
6. Isopropyrine
7. Isopropylantipyrin
8. Larodon
9. Isopropylantipyrinum
10. Propifenazona
11. Propyphenazonum
12. Propyphenazon
13. Budirol
14. Cibalgina
15. Yoshipyrin
16. 1,5-dimethyl-2-phenyl-4-propan-2-ylpyrazol-3-one
17. 1-phenyl-2,3-dimethyl-4-isopropyl-3-pyrazolin-5-one
18. 1-phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one
19. 4-isopropyl-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one
20. Antipyrine, 4-isopropyl-
21. Chebi:135538
22. 3h-pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-4-(1-methylethyl)-2-phenyl-
23. Oed8fv75py
24. 4-isopropyl-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one
25. 2,3-dimethyl-4-isopropyl-1-phenyl-3h-pyrazolin-5-one
26. 3-pyrazolin-5-one, 2,3-dimethyl-4-isopropyl-1-phenyl-
27. 3-pyrazolin-5-one, 4-isopropyl-2,3-dimethyl-1-phenyl-
28. 1,5-dimethyl-2-phenyl-4-(propan-2-yl)-1,2-dihydro-3h-pyrazol-3-one
29. Propyphenazone (4-isopropylantipyrine)
30. 4-isopropylantipyrine;isopropylphenazone
31. Propyphenazone (inn)
32. 4-isopropyl-1,5-dimethyl-2-phenyl-1h-pyrazol-3(2h)-one
33. Ncgc00164612-01
34. Isopropchin
35. Propifenazone
36. 4-isopropyl-1,5-dimethyl-2-phenyl-1,2-dihydro-3h-pyrazol-3-one
37. Dsstox_cid_3529
38. Dsstox_rid_77065
39. Propyphenazone [inn]
40. 4-isopropyl-2,3-dimethyl-1-phenyl-5-pyrazolone
41. Dsstox_gsid_23529
42. Propifenazone [dcit]
43. Causyth
44. Propifenazona [inn-spanish]
45. Propyphenazonum [inn-latin]
46. Cas-479-92-5
47. 4-isopropylphenazone
48. Ccris 6716
49. Propyphenazone [inn:ban:dcf]
50. Einecs 207-539-2
51. Unii-oed8fv75py
52. Brn 0204533
53. Yoshipyrin (tn)
54. 5-pyrazolone, 1-phenyl-2,3-dimethyl-4-isopropyl-
55. Propyphenazone,(s)
56. Chemdiv2_002457
57. Epitope Id:124928
58. Propyphenazone [mi]
59. Isopropylantipyrine (jp17)
60. Schembl23393
61. 5-24-01-00408 (beilstein Handbook Reference)
62. Mls004773970
63. Chembl28318
64. Propyphenazone [mart.]
65. Propyphenazone [who-dd]
66. Dtxsid6023529
67. Isopropylantipyrine [jan]
68. Pxwlvjlkjgvoke-uhfffaoysa-
69. Zinc49151
70. Hms1375p15
71. Hy-a0273
72. Tox21_112233
73. Mfcd00053368
74. Propyphenazone [ep Monograph]
75. S5309
76. Stk766727
77. 1,5-dimethyl-4-(1-methylethyl)-2-phenyl-1,2-dihydro-3h-pyrazol-3-one
78. Akos001725335
79. Tox21_112233_1
80. Ccg-266797
81. Cs-5533
82. Db13524
83. Ncgc00164612-02
84. Ac-12099
85. Bs-16890
86. Propyphenazone 1.0 Mg/ml In Acetonitrile
87. Propyphenazone 100 Microg/ml In Methanol
88. Smr001495368
89. Ft-0654525
90. I0656
91. D01380
92. D91192
93. Q425111
94. Sr-01000536454
95. 4-isopropylantipyrine, Analytical Reference Material
96. Sr-01000536454-1
97. W-106059
98. 4-isopropyl-1,5-dimethyl-2-phenyl-3-pyrazolone
99. Propyphenazone, European Pharmacopoeia (ep) Reference Standard
100. 4-isopropyl-1,5-dimethyl-2-phenyl-1,2-dihydro-3h-pyrazol-3-one #
101. Propyphenazone, Pharmaceutical Secondary Standard; Certified Reference Material
| Molecular Weight | 230.31 g/mol |
|---|---|
| Molecular Formula | C14H18N2O |
| XLogP3 | 1.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 230.141913202 g/mol |
| Monoisotopic Mass | 230.141913202 g/mol |
| Topological Polar Surface Area | 23.6 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 340 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
N - Nervous system
N02 - Analgesics
N02B - Other analgesics and antipyretics
N02BB - Pyrazolones
N02BB04 - Propyphenazone
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
26
PharmaCompass offers a list of Propyphenazone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Propyphenazone manufacturer or Propyphenazone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Propyphenazone manufacturer or Propyphenazone supplier.
PharmaCompass also assists you with knowing the Propyphenazone API Price utilized in the formulation of products. Propyphenazone API Price is not always fixed or binding as the Propyphenazone Price is obtained through a variety of data sources. The Propyphenazone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Budirol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Budirol, including repackagers and relabelers. The FDA regulates Budirol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Budirol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Budirol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Budirol supplier is an individual or a company that provides Budirol active pharmaceutical ingredient (API) or Budirol finished formulations upon request. The Budirol suppliers may include Budirol API manufacturers, exporters, distributors and traders.
click here to find a list of Budirol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Budirol Drug Master File in Japan (Budirol JDMF) empowers Budirol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Budirol JDMF during the approval evaluation for pharmaceutical products. At the time of Budirol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Budirol suppliers with JDMF on PharmaCompass.
A Budirol CEP of the European Pharmacopoeia monograph is often referred to as a Budirol Certificate of Suitability (COS). The purpose of a Budirol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Budirol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Budirol to their clients by showing that a Budirol CEP has been issued for it. The manufacturer submits a Budirol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Budirol CEP holder for the record. Additionally, the data presented in the Budirol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Budirol DMF.
A Budirol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Budirol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Budirol suppliers with CEP (COS) on PharmaCompass.
A Budirol written confirmation (Budirol WC) is an official document issued by a regulatory agency to a Budirol manufacturer, verifying that the manufacturing facility of a Budirol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Budirol APIs or Budirol finished pharmaceutical products to another nation, regulatory agencies frequently require a Budirol WC (written confirmation) as part of the regulatory process.
click here to find a list of Budirol suppliers with Written Confirmation (WC) on PharmaCompass.
Budirol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Budirol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Budirol GMP manufacturer or Budirol GMP API supplier for your needs.
A Budirol CoA (Certificate of Analysis) is a formal document that attests to Budirol's compliance with Budirol specifications and serves as a tool for batch-level quality control.
Budirol CoA mostly includes findings from lab analyses of a specific batch. For each Budirol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Budirol may be tested according to a variety of international standards, such as European Pharmacopoeia (Budirol EP), Budirol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Budirol USP).
